Company Filing History:
Years Active: 2018-2024
Title: **Kyle D Monroe - Innovator in PCSK9 Biology**
Introduction
Kyle D Monroe, based in Pittsford, NY, is a prominent inventor known for his significant contributions to the field of PCSK9 biology. With a remarkable portfolio of 13 patents, Monroe has developed innovative solutions aimed at modulating the activity of the PCSK9 protein, which plays a critical role in cholesterol metabolism and cardiovascular health.
Latest Patents
Monroe's latest inventions include two notable patents concerning small organic compounds that target PCSK9 protein activity. The first patent focuses on the "Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity." This invention explores how these small molecules can influence the conformation of the PCSK9 protein, thereby affecting levels of low-density lipoproteins (LDL) in circulation. High LDL-cholesterol levels are linked to an elevated risk of heart disease, while low levels can lead to complications in other conditions, such as liver dysfunction.
The second patent, "Phenylalanine small organic compounds to directly modulate PCSK9 protein activity," further expands on the use of small organic compounds as ligands for PCSK9 modulation. Like the first, this invention provides insights into how modifying the interaction between PCSK9 and low-density lipoprotein receptors can lead to either increased or decreased LDL-cholesterol levels.
Career Highlights
Kyle D Monroe has earned recognition for his work at Srx Cardio, LLC and Sxr Cardio, LLC, where he has focused on developing therapeutic strategies to address cholesterol-related health issues. His patents not only contribute to scientific advancement but also hold potential for real-world applications that can improve therapeutic outcomes for patients at risk of heart disease.
Collaborations
Throughout his career, Monroe has collaborated with notable professionals, including his coworkers Michael Mark Muehlemann and Thomas E Barta. Their joint efforts reflect a shared commitment to advancing research and development within the biotechnology sector.
Conclusion
Kyle D Monroe’s innovative approach to PCSK9 biology highlights the importance of scientific research in tackling health challenges related to cholesterol management. With a robust portfolio of patents and collaborative efforts, Monroe continues to pave the way for advancements that could ultimately lead to improved health outcomes for individuals affected by cardiovascular diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.